Interim Results Presentation July 2017 - Martyn Ratcliffe Chairman Rebecca Hemsted Finance Director - Science Group

Page created by Russell Vega
 
CONTINUE READING
Interim Results Presentation July 2017 - Martyn Ratcliffe Chairman Rebecca Hemsted Finance Director - Science Group
Interim Results Presentation
July 2017

Martyn Ratcliffe
Chairman
Rebecca Hemsted
Finance Director

To be read in conjunction with the Interim Results
announcement released on 25 July 2017

                                                     1
Interim Results Presentation July 2017 - Martyn Ratcliffe Chairman Rebecca Hemsted Finance Director - Science Group
Science Group plc - Overview
Science and technology services
• Science-based Consultancy and Advisory Services
• Technology & Product Development

Four subsidiary companies/brands
• Sagentia – founded 1986, servicing medical and commercial markets
• OTM Consulting – acq July 2013, servicing the oil and gas industry
• Oakland Innovation – acq February 2015, servicing consumer, healthcare and food & beverage markets
• Leatherhead Research – acq September 2015, servicing the food & beverage industry

Significant freehold property assets
• Cambridge – offices and laboratories based in c.100,000 sq ft freehold property
  • Sagentia and Oakland Innovation
  • Approx one third sub-let to third party tenants
• Epsom – offices and laboratories based in c.50,000 sq ft freehold property
  • Leatherhead Research and OTM Consulting
• Other offices (leased) : UK – London; USA – Boston, Houston, San Francisco

Corporate Strategy
• Board continues to explore acquisition opportunities to accelerate development of the Group
• No certainty that any transaction(s) will be completed

                                                                                                       2
Interim Results Presentation July 2017 - Martyn Ratcliffe Chairman Rebecca Hemsted Finance Director - Science Group
Financial Summary
•       Group revenue of £18.0m (H1-16: £17.7m)
    •     80% of Core Business revenue from international markets
    •     32% of Core Business revenue invoiced in US Dollars and 9% in Euros

•       Adjusted* operating profit of £3.2m (H1-16: £2.5m)
    •     Beneficial foreign exchange rates compared to H1-16
    •     Currency rates now comparable to H2-16 rates

•       Statutory PBT of £2.3m (H1-16: £1.1m)
    •     2016 PBT included £0.5m of one-off charges (Leatherhead integration and share option restructuring)

•       Adjusted* basic EPS increased to 6.1 pence (H1-16: 4.4 pence)
    • Basic EPS of 5.1 pence (H1-16: 2.4 pence) and diluted EPS of 5.0 pence (H1-16: 2.3 pence)

•       Cash balance of £26.3m (H1-16: £17.2m) and Net Funds of £12.1m (H1-16: £9.9m)
    • Net funds + freehold property per share increased to 86.2 pence (H1-16: 76.0 pence)
    • Refinancing in H2-16 with new £15m loan (10 year debt secured on freehold property)
    • Returns to shareholders since June 2016 of £4.4m – dividend and H2-2016 buy-backs

                                         *Throughout this presentation, adjusted operating profit and margin is calculated as operating profit excluding impairment of
                                         goodwill and investments, amortisation of acquisition related intangible assets, acquisition integration costs, share based payment
                                         charges and other specified items. Adjusted EPS is calculated as adjusted profit after tax divided by the weighted average
                                         number of shares in issue. This includes a tax charge at the substantively enacted UK Corporation Tax Rate for the year.

                                                                                                                                                                               3
Interim Results Presentation July 2017 - Martyn Ratcliffe Chairman Rebecca Hemsted Finance Director - Science Group
Services Revenue Profile – H1 2017
• Science Group comprises five operating businesses
• Four distinct brands under Science Group umbrella brand

                                                             Market Overview

                                             • Medical: Strong recovery performance in the
                                               period
         Leatherhead           Sagentia
                               Medical
                                             • Commercial: Quieter period due to major projects
                                               completing in second half of 2016

    Oakland
                                             • Oil & Gas: Challenging market conditions
                                               continuing

                                             • Food & Beverage: Revenue declined relative to
        OTM                                    prior year due to rationalisation during
                  Sagentia                     restructuring phase of integration
                  Commercial
                                             • Other Market Sectors: Satisfactory performance

                                                                                                  4
Group Revenue (5 Year)
• Good organic growth in Outsourced Product Development (Sagentia) business on actual
  and/or constant currency measure. Driven by recovery in Medical sector
• Non-core property rental income from Harston site stable
                 20

                 18

                 16
                                                                                                              Non Core: Property income
                 14
  Revenue (£m)

                 12
                                                                                                              Other core business revenue
                 10

                 8
                                                                                                              Core business: Services
                 6                                                                                            revenue

                 4

                 2

                 0
                      H1-12   H2-12   H1-13   H2-13   H1-14   H2-14   H1-15   H2-15   H1-16   H2-16   H1-17

                                                                                                                                            5
International Services Business
• 80% of Core Business revenue derived from international markets
• 32% of Core Business revenue invoiced in US$ (H1-16: 35%) and 9% in Euro (H1-16: 11%)
• Remaining international clients, primarily in Europe, are invoiced in GBP
• Over 90% of employees are based in the UK

  100%                                                       100%

   90%                                                       90%

   80%                                                       80%

   70%                                                       70%
                                                     Other                                                      Other
   60%                                                       60%
                                                     GBP                                                        UK
   50%                                                       50%
                                                     EUR                                                        Europe
   40%                                               USD     40%                                                North
                                                                                                                America
   30%                                                       30%

   20%                                                       20%

   10%                                                       10%

   0%                                                         0%
         H1-14 H2-14 H1-15 H2-15 H1-16 H2-16 H1-17                  H1-14 H2-14 H1-15 H2-15 H1-16 H2-16 H1-17

             Core Business Revenue by Currency                         Core Business Revenue by Geography

                                                                                                                          6
Adjusted Operating Profit
• Sagentia aggregate contribution increased due to strong Medical sector performance
• Foreign exchange benefit in H1-17 compared to H1-16
• Continuing to use part of FX benefit to increase investment
                                   4.0                                                                                           24.0%

                                   3.5

                                                                                                                                         Adjusted operating profit margin (%)
                                   3.0                                                                                           18.0%
  Adjusted operating profit (£m)

                                   2.5

                                   2.0                                                                                           12.0%

                                   1.5

                                   1.0                                                                                           6.0%

                                                                                                                                                                                Adjusted operating profit
                                   0.5                                                                                                                                          and margin is calculated as
                                                                                                                                                                                operating profit excluding
                                                                                                                                                                                impairment of goodwill and
                                                                                                                                                                                investments, amortisation of
                                   0.0                                                                                           0.0%                                           acquisition related intangible
                                         H1-12   H2-12   H1-13   H2-13   H1-14   H2-14   H1-15   H2-15   H1-16   H2-16   H1-17                                                  assets,            acquisition
                                                                                                                                                                                integration costs, share
                                                                                                                                                                                based payment charges and
                                                                                                                                                                                other specified items.

                                                                                                                                                                                                                 7
Currency Exchange Rates
• Foreign exchange benefit in H1-17 compared to H1-16
• Average USD rate of 1.26 in H1-17 (H1-16: 1.44 and H2-16: 1.29)
• Average Euro rate of 1.17 in H1-17 (H1-16: 1.30 and H2-16: 1.17)
• Exchange rates for H1-17 broadly equivalent to H2-16 levels

                  1.60

                  1.50
  Exchange rate

                  1.40                                                                                                                                                                                                                                              GBP/USD

                                                                                                                                                                                                                                                                    GBP/EUR

                  1.30

                  1.20

                  1.10

                                                                                                          30 June                                                                          31 December
                  1.00                                                                                    2016                                                                             2016
                                                                                                                            Aug-16
                                  Jan-16

                                                                               May-16
                                                                                        May-16

                                                                                                                                                       Oct-16
                                                                      Apr-16

                                                                                                                                                                                            Jan-17

                                                                                                                                                                                                                                                  May-17
                                                                                                                                                                                                                                Apr-17
                                                                                                                                                                                                                                         Apr-17
                         Dec-15

                                           Feb-16
                                                    Mar-16
                                                             Mar-16

                                                                                                 Jun-16
                                                                                                          Jul-16
                                                                                                                   Jul-16

                                                                                                                                     Sep-16
                                                                                                                                              Sep-16

                                                                                                                                                                         Dec-16
                                                                                                                                                                                  Dec-16

                                                                                                                                                                                                     Feb-17
                                                                                                                                                                                                              Feb-17
                                                                                                                                                                                                                       Mar-17

                                                                                                                                                                                                                                                           Jun-17
                                                                                                                                                                Nov-16

                                                                                                                                                                                                                                                                              8
www.sciencegroup.com

Head office              Epsom                    London
Harston Mill             Great Burgh              48-49 St James's Street
Harston, Cambridge       Yew Tree Bottom Road     London
CB22 7GG                 Epsom                    SW1A 1JT
UK                       Surrey                   UK
                         KT18 5X
                               5XT
Phone: +44 1223 875200   Phone: +44 1372 376761   Phone: +44 207 014 3250
info@sciencegroup.com    info@sciencegroup.com    info@sciencegroup.com

                                                                            9
You can also read